The 3 analysts offering 12-month price forecasts for AIM ImmunoTech Inc have a median target of 6.50, with a high estimate of 8.75 and a low estimate of 5.00. The median estimate represents a +364.29% increase from the last price of 1.40.
The current consensus among 3 polled investment analysts is to Buy stock in AIM ImmunoTech Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.10
Reporting Date Mar 31
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.